Group 1:One p a t l e n t showed bilateral intra-abclanlnal t e s t e s w l t h a n e p i d l d y m i s , a vas deferens, and a f o l l o p l a n tube.
Group 2: E l g h t p a t l e n t s showed an u n l l a t e r a l s c r o t a 1 t e s t i s and a c o n t r al a t e r a l s t r e a k gonad.
On s t r e a k gonad side, an epldldymls o r vas deferens o r b o t h were found I n 5 p a t l e n t s .
Group 3: Four w t l e n t s showed o u n l l a t e r a l i n t r a -d x l a n l n a l t e s t i s and a c o n t r al a t e r a l s t r e a k gonad.
On t h e s t r e a k gonad slde, a rudimentary vas deferens was i o u n d l n 2 p t i e n t s and o u t e r u s were found i n a l l 4 p t l e n t s . Group 4: N o p a t i e n t s showed b i l a t e r a l s t r e a k gonads associated w l t h f a l l o p l a n tube and a u t e r u s . A rudlmentory e p l d~d p~s and vas d e f e r e n s accompanied 1 out o f 4 s t r e a k gonads. Tdelve p i t l e n t s of Groups 2 and 3 were ccmpatlble w i t h a diagnosis of rnlxed gonadal dysgenesls (MGD). W o l f f i a n d u c t remnants accanpanled 7 (58%) o u t o f 1 2 s t r e a k gonads i n 12 p a t l e n t s w i t h MGD.
and 8 (50%) o u t of 16 s t r e a k gonads i n 1 4 p a t i e n t s of groups 2, 3 and 4. These findlncjs i n d i c a t e d t h a t t h e s t r e a k gonads I n c h i l d r e n w l t h 45,X and Y-contalning chromosome rnosalclsrn f r e q u e n t l y had f m c t l on i n g L e y d i g c e l l s a t l e a s t a t t h e t l m e of d l f f e r e n t l e t l o n o f t h e g e n l t a l d u c t s , a l t h o u g h none had p r o p e r l y f u n c t i o n i n g S e r t o l i c e l l s a t t h a t tlrne. T h l r t e e n p a i l e n t i i r l t h dbnor!r~dl ionadat d l f f e l e l # t l d t l o n conflrnled by pathology were s t u d l e d . Scvcn w l t l i 46,hl b a r y a t y p c ( r l x w l t h d y s y e n c t l c gonads a~l d one a l t h gonad31 a y e n e i l i ) and r l x w l t l l 46,XX l a r y o t y p e : t h r e e 46,XX t r u e h e r m l o h r o d i t e r , t w o 46,XX males (one iill.. n.ilb~guous g e n l t a l l a and t h e o t h e r wltlr normal e x t e r n a l y e n l t d t i d and gynecomastla) and one 46,XX p a t l e n t w l t h p r l m a r y gonadal f a i l u r e , b o r n from a conrangulneoui mal-t.lbye and r l i t e r o f t h e 46,XY p a t l e n t w i t h gonadal a g i n r s i i . The SRY sequence was a n p t l f > e d by PCR r l t h t h e p r l r n e r i EA and EB l o c a t e d w l t h l n t i l e SRY i o n s e r v~d sequence, anlptlfy ~n y a 317-bp fragment. The Y -s p e c l f l c DNA sequence IFY was d e t e c t i d b y Sout1iu1.n h y b r l d l i a t l o n s u s l n g t h e pOP1007 probe, whlch corresponds t o a Y -~h r o n~o s o n~e sfyrncnt rndppIng c l o s e t o t l l c t e i t l r d e t r r t n l n l n g f a c t o r regton. The Z F Y sequence was analysed i n 8 Cases ( t h r e e 46,XX and five 46,XY p a t l e n t r ) and found t o be present ,n a l l 46,XY p a t i e n t s b e l n g absent i n t h e 46,XX p a t l e n t s . The SRY sequence war d n a l y i r d by PCR I n 8 cases ( f o u r 46,XX p a t l e n t s and f o u r 46,XY p a i l e n t i ) b e i n g p r e s e n t ~n onc 46,XX p a t l e n t ( a t r u e lhermaphradlte) and I " a l l 46,XY (gonadal d y i g e n e i l s p a t t e n t i ) and absent I" t h r e e 46,XX p d t l e n t s .
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I t was concluded t h a t : a ) -t u i t l c u l a r d l f f e r e r t l a t > o r l can occur ~n t h e absence of t h e Y-chronosome sequences SRY and ZFY. b)-gonadal d y r g e n r r l r I " SRY and Z F Y -p o i l t l v e p a t i e n t s c o u l d be caused b y m u t a t l o n r , o u t o f t h e SRY and ZFY l o c l , c)-46,XX and 46,XY gonadal a g e n e s l i p r e s e n t I " two s l s t e r i born from consanyulneous marrlage suggest a rote f o r a~t o i~m a l loci I n gonadal d l f f e r c n t i a t l o n . Androgen insens~tlv~ty syndromes have d~lferent phenolypes, depend~ng on severlty 01 the receptor defect, whlch !n turn dfvends on the Ivpe of androaen receptor aene mutallon A molecular geneltc based subclas;~f~cat~on may help to delln'ithose, who i r e responsive to h~gh dose androgen therapy We report two brothers who were successfully treated w~th hlgh doses of testosterone Pal~mfs: Two brolhers. 115112 (A) and 1 5 3~1 2 (B) years, had mlcropenls, penoscrotat hypospad~as and choidee Penis slze was 3 and 3.5 cm, resp Results: Basal serum hormone levels (LH, FSH teslosterone, DHT) were prepubenai In (A). LH was Increased In ( 8 ) ( 1 3 . 3 UIL). The androgen sensltlvtty lest revealed a pantal defect of androgen actton, as ev~denced by a decreased SHBG response lo the anabollc slerojd slanozolol (nadlr 71% ;illJ 66 %, resp) DNA analysts revealed a single base subsl~tul~on (T to G) in the hormone-blndlng region (exon 7) ol Ihe androgen receptor gene whlch causes a Val-Leu substilut~on In codon 866 Treatment was inft~ated wllii 500 mg testosterone enanlliate, Im, every 2 weeks Pen18 sue Increased to 8 5 (A) and 9 (0) cm, pub~c halr reached Tanner staqe 5, volce broke, a mousiache, axlllary ha~r and were ~ncreased (2 weeks after Ihe last ~njectlon) Conclusion: High dose androgen trealment produced pubenat v~r~t~zatioli and ph3ll~c growth In both pattents The pan~al Impaliment ol androgen receptor funct~on may be overcome by supraphysiolog~cal serum concenlrat~ons of teslosterone Thus, such treatment seems lo be lndlcated ln certa~n 0. H l o r t a n d G.H.G. S~n n e c k e r , Department of P e d~a t r i c s , Medlcal U n i v e r s~t y of Ldbeck, Lubeck, Germany
Germlnai p o i n t mutations w i t h i n t h e a n d r o g e n r e c e p t o r (AR) gene cause a heterogenous g r o u p o f a n d r o g e n i n s e n s i t i v i t y s y n d r o m e s (AIS). Assessment of residual f u n c t i o n o f AR m u t a n t s i s i m p o r t a n t f o r g e n d e r assignment a n d p r e d i c t i o n of p u b e r t a l development i n p a t l e n t s w i t h AIS. We h a v e u s e d an I n v i v o t e s t i n v o l v i n g t h e sex hormone-binding g l o b u l i n (SHBG) decline i n response t o t h e anabollc s t e r o i d stanozolol ( 1 )
t o c h a r a c t e r i z e a n d r o g e n s e n s i t i v i t y i n s u b j e c t s w i t h p a r t i a l AIS i n whom a d i s t i n c t m u t a t i o n o f t h e AR aene has been d e f i n e d (2). Patients: S u b j e c t 1 has a female p h e n o t y p e w i t h s u b t l e n a r r o w i n g of t h e vaglnai i n t r o i t u s w i t h o u t c l i t o r a l enlarsement. S u b i e c t s 2 a n d 3 a r e b r o t h e r s who i n i t i a l l y w i t h micropenis and hypospadias, a n d a t t h e time of p u b e r t y developed gynecomastia.
Results:
A G-A t r a n s v e r s i o n c a u s i n g an a r g i n i n e t o h i s t i d i n e exchange in p o s i t i o n 840 of t h e AR gene was c h a r a c t e r i z e d i n p a t i e n t 1. SHBG f e l l t o 8 1 % of ~n i t l a l value. I n p a t i e n t s 2 a n d 3 a G-T s u b s t i t u t i o n leads t o a v a l i n e t o leucine exchange I n codon 866. Patient 2 h a d a SHBG decltne t o 6 6 % , while h i s b r o t h e r had a decline t o 71% o f i n i t i a l value. Conclusion: S t u d i e s of p a t i e n t s c a r r y i n g AR m u t a n t s u s i n g t h e SHBG t e s t i n v i v o may p r o v i d e physiol6gicaiiy r e l e v a n t functional information a b o u t t h e AR a n d may p e r m i t c l i n~c a l i y valuable genotype-phenotype prediction. F u r t h e r t e s t s i n p a t i e n t s w i t h AR m u t a t i o n s a r e i n progress. 
FPR have been oerformed i n d i r e c t l v w i t h r a d i o t r a c e r i n f u s i o n s and prolonged, ' q u a n t i t a t i v e u r i n e > o l l e ct i o n s ; techniques t h a t a r e d i f f i c u l t o r u n e t h i c a l i n i n f a n t s .
c h i l d r e n and preqnant women. U t i l i z i n a 9,9.12-2tb C o r t i s o l (D3F) and gas chromatography-mass spectroscopy. we have developed a
s t r a i g h t f o r w a r d method f o r t h e d e t e r m i n a t i o n o f 03F enrichment o f c o r t i s o l (F)
. The method r e q u i r e s 4 e x t r a c t i o n steps b u t i s e a s i l y accomplished w i t h 1 mL plasma. To determine whether such methods could' a c c u r a t e l y p r e d i c t e n t r y o f F i n t o t h e plasma space. f i v e dexamethasone suppressed, p o s t -a b s o r p t i v e a d u l t s were i n f u s e d w i t h p r e c i s e l y known q u a n t i t i e s o f F and 03F. We t e s t e d whether t h e method was a b l e t o p r e d i c t t h e r a t e of F i n f u s i o n . On each o f two s t u d y days, t h e s u b j e c t s r e c e i v e d a continuous, nonprimed 12 h r i n f u s i o n o f D3F. From h r s 4-8 and 8-12 on each day. F i n f u s i o n s were used t o achieve F c o n c e n t r a t i o n p l a t e a u s o f 7.8. 17.4. 25.8 and 35.7 ~g / d L , r e s p e c t i v e l y . Near i s o t o p e and hormone steady s t a t e ( v a r i a n c e <lo%) was achieved by h r 3 o f each plateau. The i s o t o p e d i l u t i o n method p r e d i c t e d FPR w i t h a mean e r r o r i n s i gn i f i c a n t l y d i f f e r e n t from t h a t expected by p r o p a g a t i o n o f e r r o r a n a l y s i s . We conclude t h a t o u r methods employinq s t a b l e isotopes can a c c u r a t e l y p r e d i c t t h e e n t r y o f F i n t o t h e piasma space d u r i n g steady s t a t e c o n d i t i o n s and a r e s u i t a b l e f o r e x p l o r i n g F product i o n i n humans o f a l l ages. n o r m s l i r s f t o n o f plasma VLCiA l e v e l s I" ALD p a f l e n f r . Thus t h e d a t a suggest t h s t t h e pathological changes a f f e c f > n g t h e nervous end endocrine system nay be delayed, o r even a r r e s t e d , i n these p a f l e n t s . Ye nou r e p o r t t h e e f f e c t s on t h e clinical course o f ALD o f t h l s f h e r e p e u t i c epprosch ~n 18 p s t l e n t s t r e a t e d u i t h dietary-GTOE r u p p l e m e n f a o o n up t o 5 years. There war no e f f e c t on t h e c l i n l c s l course ~n p s t l e n t r u i t h childhood dnd adolescent ALD assessed b y n e u r o l o g i c a l , n e u r~p s y c~l~g i~s l and n e u r o r e d~o l o g~c s l (UMI) e v s l u s t i o n s . P a t i e n t s u i r h sdren~rnyeloneropsfhy and presymptomstlc d l d nor e x h l b i t p r o g r e s s i o n o f t h e d~b e e s e . A l l b u t 3 p a f n e n t h h a d hyp0sdrenallbm. Pleama e l d o s t e r o n e l e v e l s "ere reduced and PRA was ~n c r e s s e d . l n t e r c s t l n g l y , n o r m a l l s a t i o n o f VLCFA l e v e l s i n these p a t l e n t s r e s u l t e d ~n an lncrearc o f aldoarerone (MSD: 112.394.6 vs 379.2~12.1 p g l m l , p<0.051 and a r e d u c t r o n o f PRA Levels from 10.227.6 t o 5.122.8 nglmlfh, confnrmlnp t h s t VLCFA excess has a d a r e c t fox>= n f f e c t on r h c a d r e n a l 8 herea as o t h e r f a c t o r s a r e more l l k e l y i n v o l v e d ln t h e d c t e r m i n a t l o n o f t h e p a t h o l o g~~a l changer ~n t h e nervous system. S17 ( R t c e r c s c o r r e o t e PlfO21PIZC5. l l > n~s f e r o d e l l s S a n i t a I t a l > s n o )
